Holen Sie sich die Stockscreener-App
5.14
2.80%
0.14
Schlusskurs vom Vortag:
$5.00
Offen:
$5
24-Stunden-Volumen:
8.08M
Relative Volume:
1.56
Marktkapitalisierung:
$1.37B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-252.18M
KGV:
-4.8491
EPS:
-1.06
Netto-Cashflow:
$-185.29M
1W Leistung:
+0.19%
1M Leistung:
+26.60%
6M Leistung:
+102.36%
1J Leistung:
+151.96%
1-Tages-Spanne:
$4.865
$5.35
1-Wochen-Bereich:
$4.252
$5.427
52-Wochen-Spanne:
$1.26
$7.30
Sana Biotechnology Inc Stock (SANA) Company Profile
Firmenname
Sana Biotechnology Inc
Sektor
Branche
Telefon
(206) 701-7914
Adresse
188 EAST BLAINE STREET, SUITE 400, SEATTLE
Vergleichen Sie SANA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
5.14 | 1.33B | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-24 | Eingeleitet | Wedbush | Outperform |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-03-18 | Hochstufung | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | Eingeleitet | Jefferies | Buy |
| 2025-01-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-11-05 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-01-16 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-05 | Eingeleitet | Citigroup | Buy |
| 2023-08-14 | Eingeleitet | TD Cowen | Market Perform |
| 2023-05-02 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-03-01 | Eingeleitet | BofA Securities | Buy |
| 2021-03-01 | Eingeleitet | Goldman | Neutral |
| 2021-03-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-03-01 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Sana Biotechnology Inc Aktie (SANA) Neueste Nachrichten
Sana Biotechnology Reports Reduced Losses and Strong Liquidity - MSN
Sana Biotechnology (NASDAQ:SANA) Trading Up 8.8%Still a Buy? - MarketBeat
Sana Biotechnology (SANA): Valuation Check After New In Vivo Gene Editing Data in Nature Biotechnology - Sahm
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Sana Biotechnology Stock: Soar or Sputter? - StocksToTrade
Sana Biotechnology (NASDAQ:SANA) Shares Down 5.9%Time to Sell? - MarketBeat
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform - The Manila Times
Sana Biotechnology (NASDAQ: SANA) Nature Biotech data show in vivo HSC gene editing - Stock Titan
Buyout Rumor: How Sana Biotechnology Inc stock performs in weak economyNew Guidance & Daily Profit Maximizing Trade Tips - moha.gov.vn
Sana (SANA) Surges 14.5% Ahead of Business Announcements - MSN
Is Sana Biotechnology's (SANA) SC451 Pivot Quietly Redefining Its Long-Term Platform Strategy? - simplywall.st
Flagship Pioneering, Cambridge University Health Partners, and Milner Therapeutics Institute Announce Collaboration to Accelerate Biotech Research and Innovation - Quantisnow
Sana Biotechnology’s Surging Stock: Buy or Sell? - StocksToTrade
Flagship Pioneering Appoints Angela Hwang as CEO-Partner and Chief Executive Officer of Metaphore Biotechnologies - Quantisnow
Sana Biotechnology (NASDAQ:SANA) Trading Up 6.6%Should You Buy? - MarketBeat
Sana Biotechnology (SANA) Stock Analysis Report | Financials & Insights - Benzinga
Will Sana Biotechnology’s (SANA) Pipeline Focus Reveal Strategic Priorities in Diabetes and Autoimmune Innovation? - Yahoo Finance
Sana Biotechnology Beats Earnings Estimates, Prioritizes SC451 and CAR T - StocksToTrade
Sana Biotechnology Surges Amid Strong Q3 Earnings Performance - timothysykes.com
Sana Biotechnology (SANA): Assessing Valuation After Strong Year-to-Date Share Price Gains - Yahoo Finance
Sana Biotechnology (SANA): Evaluating Valuation After Recent Surge in Share Price - Sahm
10 Small Stocks with Mighty Gains - Insider Monkey
Sana Biotechnology (NASDAQ:SANA) Trading 12.8% HigherStill a Buy? - MarketBeat
Sana Biotechnology to Present at December 2025 Investor Conferences - GlobeNewswire
Sana Biotechnology, Inc. to Webcast Presentations at December Investor Conferences - Quiver Quantitative
Sana Biotechnology (NASDAQ: SANA) to Present at 2025 Citi and Evercore Conferences - Stock Titan
Sana Biotechnology (NASDAQ:SANA) Stock Rating Lowered by Wall Street Zen - MarketBeat
Citi Maintained a Buy Rating on Sana Biotechnology (SANA) - MSN
Why Sana Biotechnology Inc. stock could benefit from AI revolutionWatch List & Fast Gaining Stock Strategy Reports - newser.com
Can Sana Biotechnology Inc. stock deliver surprise earnings beat2025 Year in Review & Fast Gain Stock Trading Tips - newser.com
How Sana Biotechnology Inc. stock benefits from global expansion2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
Evaluating Sana Biotechnology Inc. with trendline analysisJuly 2025 Sentiment & Expert Curated Trade Ideas - newser.com
What valuation multiples suggest for Sana Biotechnology Inc. stock2025 Big Picture & Free AI Powered Buy and Sell Recommendations - newser.com
Using Ichimoku Cloud for Sana Biotechnology Inc. technicalsJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com
Will Sana Biotechnology Inc. stock benefit from automationBull Run & Daily Risk Controlled Trade Plans - newser.com
The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care - Markets Financial Content
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength - Insider Monkey
Can Sana Biotechnology Inc. recover in the next quarterTreasury Yields & Fast Exit and Entry Trade Guides - newser.com
Finanzdaten der Sana Biotechnology Inc-Aktie (SANA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sana Biotechnology Inc-Aktie (SANA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Wyrick Susan D. | See Remarks |
Jun 03 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
170,395 |
| Wyrick Susan D. | See Remarks |
Mar 07 '25 |
Option Exercise |
0.00 |
3,250 |
0 |
158,231 |
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):